Financials Medpace Holdings, Inc.

Equities

MEDP

US58506Q1094

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 04:00:00 2024-09-13 pm EDT			5-day change	1st Jan Change
351.67 ^USD	+1.95%		+4.74%	+14.73%

Aug. 26	Medpace Holdings Insider Sold Shares Worth $3,175,463, According to a Recent SEC Filing	MT
Aug. 15	Skanska Builds New Office Building in Cincinnati, Ohio, USA, for USD 164 Million, About SEK 1.7 Billion	CI

Projected Income Statement: Medpace Holdings, Inc.

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Net sales ¹	861	925.9	1,142	1,460	1,886	2,141	2,418	2,776
Change	-	7.54%	23.38%	27.8%	29.17%	13.54%	12.94%	14.8%
EBITDA ¹	149.6	187.8	223.1	308.1	362.5	445.9	499.8	582.3
Change	-	25.51%	18.81%	38.12%	17.65%	23%	12.1%	16.5%
EBIT ¹	141.2	176.1	207.1	285.8	338.4	414.9	467.9	548.4
Change	-	24.69%	17.59%	38%	18.41%	22.61%	12.79%	17.19%
Interest Paid	-1.568	-	-0.105	-2.905	-0.488	-	-	-
Earnings before Tax (EBT) ¹	124.8	168.5	201.9	282.9	335.7	441.1	499	580.6
Change	-	35.01%	19.77%	40.13%	18.67%	31.41%	13.12%	16.36%
Net income ¹	100.4	145.4	181.8	245.4	282.8	372.4	419.7	487.4
Change	-	44.74%	25.08%	34.93%	15.26%	31.68%	12.7%	16.14%
Announcement Date	2/24/20	2/15/21	2/14/22	2/13/23	2/12/24	-	-	-

¹USD in Million

Estimates

Fiscal Period: December	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2
Net sales ¹	216.2	229.9	230.9	205	230.4	259.7	260	278.3	295.6	308.6	330.9	351.2	383.7	394.1	434.1	460.9	492.5	498.4	511	528.1	542.4	554.4	570.4	592.2	616.6	633.7	657.8	683
Change	-	6.31%	0.43%	-11.21%	12.38%	12.72%	0.11%	7.05%	6.21%	4.39%	7.26%	6.12%	9.26%	2.7%	10.14%	6.17%	6.86%	1.2%	2.54%	3.34%	2.71%	2.2%	2.89%	3.83%	4.12%	2.77%	3.8%	3.83%
EBITDA ¹	34.78	41.15	40.57	35.02	51.95	60.21	53.61	47.94	60.11	61.41	70.38	68.09	89.26	80.37	92.85	83.63	90.18	95.84	115.7	112.3	109.3	112.1	120.3	123.9	124.6	128.2	140.6	144.6
Change	-	18.33%	-1.4%	-13.68%	48.33%	15.91%	-10.96%	-10.58%	25.38%	2.16%	14.61%	-3.25%	31.09%	-9.96%	15.53%	-9.93%	7.84%	6.27%	20.68%	-2.94%	-2.67%	2.64%	7.28%	3.02%	0.57%	2.89%	9.63%	2.83%
EBIT ¹	32.71	38.82	38.12	32.35	48.96	56.68	49.8	43.99	56.06	57.22	66.11	63.38	84.31	74.47	87.44	77.66	83.86	89.41	109	105.4	102	104.6	112	115.1	117.3	120.7	132.5	136.4
Change	-	18.68%	-1.82%	-15.14%	51.35%	15.78%	-12.14%	-11.66%	27.42%	2.08%	15.53%	-4.12%	33.02%	-11.67%	17.41%	-11.19%	7.98%	6.63%	21.93%	-3.34%	-3.18%	2.57%	7.07%	2.72%	1.95%	2.89%	9.76%	2.9%
Charge d'intérêts	-	0.388	-	-	-	-	-0.014	-0.027	-0.041	-0.023	0.054	-0.548	-1.584	-0.827	-0.861	-1.366	-0.105	-	-	-	-	-	-	-	-	-	-	-
Earnings before Tax (EBT) ¹	29.46	36.22	36.48	30.36	46.99	54.7	48.51	42.69	54.74	55.92	65.32	62	81.89	73.64	86.03	75.74	83.2	90.71	112.8	110.5	108.6	112.3	119.9	121.3	124.5	128.9	140.5	142.9
Change	-	22.92%	0.72%	-16.77%	54.77%	16.41%	-11.32%	-12%	28.23%	2.16%	16.81%	-5.09%	32.09%	-10.07%	16.82%	-11.96%	9.85%	9.02%	24.34%	-2.04%	-1.69%	3.41%	6.79%	1.17%	2.59%	3.57%	8.95%	1.7%
Net income ¹	23.98	29.81	28.95	24.1	41.46	50.87	43.31	39.93	48.57	50.03	61.31	49.36	66.03	68.67	72.89	61.07	70.55	78.3	102.6	88.35	90.46	93.67	100.6	101.8	104.4	108.1	117.8	119.8
Change	-	24.34%	-2.88%	-16.75%	72%	22.69%	-14.86%	-7.79%	21.64%	3.01%	22.54%	-19.49%	33.77%	4%	6.15%	-16.22%	15.53%	10.98%	31.03%	-13.88%	2.39%	3.55%	7.38%	1.2%	2.53%	3.6%	8.91%	1.71%
Announcement Date	10/28/19	2/24/20	4/28/20	7/27/20	10/26/20	2/15/21	4/26/21	7/26/21	10/25/21	2/14/22	4/25/22	7/25/22	10/24/22	2/13/23	4/24/23	7/24/23	10/23/23	2/12/24	4/22/24	7/22/24	-	-	-	-	-	-	-	-

¹USD in Million

Estimates

Forecast Balance Sheet: Medpace Holdings, Inc.

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Net Debt ¹	-132	-278	-461	161	-103	-717	-951	-1,268
Change	-	-310.61%	-265.83%	-65.08%	-163.98%	-793.91%	-232.64%	-233.33%
Announcement Date	2/24/20	2/15/21	2/14/22	2/13/23	2/12/24	-	-	-

¹USD in Million

Estimates

Cash Flow Forecast: Medpace Holdings, Inc.

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
CAPEX ¹	17.91	31.34	28.27	36.88	36.65	42.98	44.73	49.09
Change	-	74.97%	-9.79%	30.45%	-0.63%	17.27%	4.08%	9.73%
Free Cash Flow (FCF) ¹	184	227.3	235.1	351.2	396.7	432.7	513.9	587.3
Change	-	23.58%	3.4%	49.4%	12.97%	9.08%	18.74%	14.28%
Announcement Date	2/24/20	2/15/21	2/14/22	2/13/23	2/12/24	-	-	-

¹USD in Million

Estimates

Forecast Financial Ratios: Medpace Holdings, Inc.

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Profitability
EBITDA Margin (%)	17.37%	20.28%	19.53%	21.1%	19.22%	20.82%	20.67%	20.98%
EBIT Margin (%)	16.4%	19.02%	18.13%	19.57%	17.94%	19.38%	19.35%	19.75%
EBT Margin (%)	14.5%	18.2%	17.67%	19.37%	17.8%	20.6%	20.64%	20.92%
Net margin (%)	11.67%	15.7%	15.92%	16.81%	15%	17.39%	17.36%	17.56%
FCF margin (%)	21.37%	24.55%	20.58%	24.05%	21.04%	20.21%	21.25%	21.16%
FCF / Net Income (%)	183.14%	156.37%	129.26%	143.12%	140.28%	116.2%	122.43%	120.48%
Profitability
ROA	10.73%	-	11.92%	16.29%	18.8%	19.11%	16.57%	15.59%
ROE	17.22%	19.87%	20.68%	36.64%	59.83%	47.41%	36.59%	35.14%
Financial Health
Leverage (Debt/EBITDA)	-	-	-	0.52x	-	-	-	-
Debt / Free cash flow	-	-	-	0.46x	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	2.08%	3.38%	2.47%	2.53%	1.94%	2.01%	1.85%	1.77%
CAPEX / EBITDA (%)	11.97%	16.69%	12.67%	11.97%	10.11%	9.64%	8.95%	8.43%
CAPEX / FCF (%)	9.74%	13.79%	12.03%	10.5%	9.24%	9.93%	8.71%	8.36%
Items per share
Cash flow per share ¹	5.372	6.86	6.985	11.52	13.61	16.39	15.75	17.7
Change	-	27.69%	1.83%	64.99%	18.1%	20.41%	-3.92%	12.38%
Dividend per Share ¹	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Book Value Per Share ¹	19.33	21.37	25.28	11.48	17.55	30.77	36.56	44.57
Change	-	10.56%	18.3%	-54.6%	52.97%	75.28%	18.82%	21.91%
EPS ¹	2.67	3.84	4.81	7.28	8.88	11.59	13.04	15.23
Change	-	43.82%	25.26%	51.35%	21.98%	30.49%	12.54%	16.82%
Nbr of stocks (in thousands)	35,812	35,572	35,754	31,018	30,683	30,932	30,932	30,932
Announcement Date	2/24/20	2/15/21	2/14/22	2/13/23	2/12/24	-	-	-